Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Frizzled class receptor 3 (FZD3) is a member of the frizzled family of G protein-coupled receptors (GPCRs), characterized by seven transmembrane domains and serving as receptors for Wnt proteins[2][4][1]. FZD3 is critically involved in non-canonical Wnt signaling, particularly planar cell polarity (PCP) pathways that regulate axonal development in the nervous system and neural crest cell migration[1][2][3]. It is also implicated in the canonical β-catenin pathway, with possible roles in hair follicle development and other tissue-specific functions. Disease associations include cancer (notably colorectal cancer), multicystic dysplastic kidney, and genetic susceptibility for schizophrenia[4][1]. Although no approved drugs specifically target FZD3, recent advances include nanobody modulators and characterization of conserved pockets that may be druggable with small molecules[1]. Safety concerns stem from FZD3’s roles in essential developmental and homeostatic processes, raising potential challenges for selective therapeutic intervention.
Nanobody modulators can act as antagonists or agonists by competing with Wnt ligands or intracellular effectors (Dishevelled proteins, G protein coupling) Small molecule inhibitors (potential) that block the transmembrane ligand binding groove
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Frizzled class receptor 3 (FZD3).